Addex Therapeutics is a clinical-stage biopharmaceutical company focused on developing a portfolio of novel small molecule allosteric modulators for neurological disorders.
Products, services, technology
- Dipraglurant for post-stroke sensorimotor recovery
- ADX71149 (mGlu2 Pam) - indication under evaluation
- GABAB PAM for substance use disorder
- GABAB PAM for chronic cough
- http://www.addextherapeutics.com
- +41 22 884 15 55
- Send an email
- Tim Dyer
